Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

39°
- Bishop, CA (93514)
  Today
  
  Light rain early. A mix of sun and clouds by afternoon. High 56F. Winds S at 10 to 20 mph. Chance of rain 70%..
  
  Tonight
  
  Clear skies. Low 27F. Winds NW at 5 to 10 mph.
  
  Updated: February 11, 2026 @ 5:59 am
- Full Forecast

Site search

Home
News
Sports
Obituaries
e-Edition
Special Sections
Classifieds
- Place an ad
Archives

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Embecta Corp. - Common Stock (NQ:EMBC)

10.15 -0.14 (-1.36%)

Streaming Delayed Price Updated: 9:32 AM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Embecta Corp. - Common Stock

< Previous 1 2 3 Next >

Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination

February 09, 2026

Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5...

Via Finterra

3 Healthcare Stocks Paying the Highest Dividends of 2026 ↗

February 06, 2026

Which of the highest-yielding healthcare stocks are value traps or golden opportunities?

Via The Motley Fool

Embecta (EMBC) Q1 2026 Earnings Call Transcript ↗

February 05, 2026

Embecta (EMBC) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Embecta Corp (NASDAQ:EMBC) Stock Falls 6.5% on Q1 Revenue Miss Despite EPS Beat ↗

February 05, 2026

Via Chartmill

An Overview of Embecta's Earnings ↗

August 07, 2025

Via Benzinga

A Peek at Embecta's Future Earnings ↗

May 08, 2025

Via Benzinga

Earnings Scheduled For February 6, 2025 ↗

February 06, 2025

Via Benzinga

Precision Medicine and the Tubeless Revolution: An In-Depth Look at Insulet Corporation (PODD)

January 09, 2026

Today’s Date: January 9, 2026 Introduction In the rapidly evolving landscape of medical technology, few companies have managed to fundamentally reshape a multi-decade standard of care as successfully...

Via PredictStreet

Topics Economy Product Recall World Trade

Embecta (EMBC) Q4 2025 Earnings Call Transcript ↗

November 25, 2025

Embecta (EMBC) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Embecta Corp (NASDAQ:EMBC) Reports Q4 Earnings Miss, Provides FY 2026 Outlook ↗

November 25, 2025

Embecta (EMBC) reported Q4 earnings, missing EPS and revenue estimates. The stock rose as investors focused on the company's positive fiscal 2026 guidance and dividend.

Via Chartmill

Topics Earnings

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 08, 2025

Via Benzinga

Uncovering Potential: Embecta's Earnings Preview ↗

November 25, 2024

Via Benzinga

Embecta Corp (NASDAQ:EMBC) Surpasses Q3 Earnings Estimates, Shares Jump 10.5% in Pre-Market Trading ↗

August 08, 2025

Embecta Corp (EMBC) beats Q3 2025 earnings estimates with $295.5M revenue and $1.12 EPS, sparking a 10.5% pre-market stock surge. Strong performance may lift full-year forecasts.

Via Chartmill

Earnings Scheduled For August 8, 2025 ↗

August 08, 2025

Via Benzinga

Why Is Embecta Stock Falling On Friday? ↗

May 09, 2025

Embecta reaffirms earnings outlook, trims revenue forecast, and boosts cash flow as restructuring and cost controls offset tariff and FX headwinds.

Via Benzinga

Topics World Trade

Earnings Scheduled For May 9, 2025 ↗

May 09, 2025

Via Benzinga

Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business ↗

February 06, 2025

Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.

Via Benzinga

Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit ↗

February 03, 2025

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to...

Via Benzinga

Aehr Test Systems Posts Weak Results, Joins Trump Media & Technology Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 14, 2025

Via Benzinga

Topics Government

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

This Dick's Sporting Goods Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday ↗

November 27, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 26, 2024

Via Benzinga

Crude Oil Moves Lower; Dick's Sporting Goods Earnings Top Views ↗

November 26, 2024

Via Benzinga

Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps ↗

November 26, 2024

Embecta reports fourth quarter earnings beating estimates, discontinues insulin patch program, and announces restructuring plans with cost-saving measures.

Via Benzinga

Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Results ↗

November 26, 2024

Via Benzinga

J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday ↗

November 26, 2024

Via Benzinga

Earnings Scheduled For November 26, 2024 ↗

November 26, 2024

Via Benzinga

EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024 ↗

August 09, 2024

EMBC stock results show that Embecta beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.

Via InvestorPlace

Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off ↗

July 23, 2024

Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The company's U.S. business has struggled with the rise of GLP-1 drugs and...

Via Benzinga

Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 22, 2024

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Local Events
Obituaries
Multimedia
Online Features
Announcements

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Contact Information

InyoRegister.com
407 W. Line St. #8
Bishop, CA 93514
Phone: 760-873-3535

Advertising

Retail Sales: egalanski@inyoregister.com
Classified Sales: classy@inyoregister.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Bishop, CA (93514)

Today

Tonight

Embecta Corp. - Common Stock (NQ:EMBC)

Headline News about Embecta Corp. - Common Stock

Sections

Services

Contact Information